+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Female Contraceptive Market by Product Type, Mechanism, End User Age, Distribution Channel - Global Forecast 2026-2032- Product Image
Female Contraceptive Market by Product Type, Mechanism, End User Age, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Female Contraceptive Market by Product Type, Mechanism, End User Age, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904506
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Female Contraceptive Market is projected to reach USD 18.40 Billion in 2026. It is expected to continue growing at a CAGR of 8.16%, reaching USD 29.55 Billion by 2032.

The female contraceptive market is a core pillar of reproductive health, spanning hormonal contraceptive pills, intrauterine devices, implants, injectables, patches, vaginal rings, barrier methods, and emergency contraception. Demand is underpinned by the need to prevent unintended pregnancy, support maternal health, and expand reproductive autonomy across high-income and emerging healthcare systems.

WHO reports that more than 1.1 billion women of reproductive age need family planning, and UNFPA has highlighted that hundreds of millions still have an unmet need for modern contraception. This gap makes product availability, counseling quality, affordability, safety, privacy, and method choice central competitive factors for manufacturers, distributors, healthcare providers, and public health programs.

Transformative Shifts in the Female Contraceptive Landscape

The female contraceptive landscape is shifting from one-size-fits-all contraception toward broader method choice, longer-acting options, and patient-centered access models. Long-acting reversible contraceptives, including IUDs and implants, continue to gain clinical attention because they reduce adherence burden, while oral contraceptives remain important due to familiarity, accessibility, and established prescribing pathways.

Policy and channel dynamics are equally transformative. Over-the-counter access to selected oral contraceptives, telehealth prescribing, pharmacy-based services, and direct-to-consumer digital platforms are changing how women obtain contraception. At the same time, safety monitoring, equity concerns, informed consent, and supply reliability are becoming decisive factors in procurement, prescribing confidence, and brand trust.

Cumulative Impact of AI on Female Contraception

Artificial intelligence is increasingly relevant to the female contraceptive ecosystem, particularly in demand planning, inventory optimization, adverse event signal detection, and digital patient engagement. AI-enabled analytics can help providers identify discontinuation risks, support adherence reminders, and tailor educational content by age, medical history, contraindications, and preference profile.

The cumulative impact is operational as much as clinical. Manufacturers can use AI to improve pharmacovigilance workflows and supply chain resilience, while payers and public programs can model access gaps at a community level. However, AI deployment must remain clinically governed, privacy-compliant, transparent, and bias-tested to avoid reinforcing disparities in reproductive healthcare.

Key Regional Insights for Female Contraceptives

Asia-Pacific combines large reproductive-age populations with uneven access to counseling and modern contraceptive methods. China, India, Japan, South Korea, Australia, and ASEAN markets differ widely in regulatory pathways, reimbursement, urban-rural access, provider capacity, and cultural preferences, creating opportunities for both affordable oral contraceptives and clinician-administered long-acting reversible contraceptives.

North America is characterized by high awareness, established prescribing infrastructure, and growing interest in pharmacy access and telehealth, while Europe benefits from national health systems, strong regulatory oversight, and mature reproductive health services. Latin America shows sustained demand for affordable modern contraception, with Brazil and Mexico serving as important access markets where public programs, pharmacies, and clinician counseling shape method uptake.

The Middle East and Africa remain highly heterogeneous. GCC countries are shaped by private healthcare growth, women’s health investment, and physician-led decision-making, whereas many African markets continue to face unmet need, financing constraints, stockout risks, and last-mile distribution challenges. Across both regions, reliable supply, culturally competent counseling, trained providers, and public-private partnerships are critical access enablers.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets present a mixed opportunity profile, with rising healthcare access, young populations, and increasing digital health adoption supporting demand for modern contraception. Public sector procurement remains influential, while private pharmacies, clinics, and mobile health channels are expanding method availability in urban centers and improving awareness among younger consumers.

The GCC is driven by healthcare modernization, private-sector investment, and growing attention to women’s wellness, although adoption patterns remain closely linked to cultural norms, physician guidance, and privacy expectations. The European Union offers a highly regulated and evidence-driven environment where reimbursement, pharmacovigilance, patient information standards, and national family planning policies shape market access.

BRICS countries provide scale and long-term demand potential because they include major population centers such as Brazil, Russia, India, China, and South Africa, with diverse public health priorities and manufacturing capabilities. G7 markets are generally mature, innovation-sensitive, and policy-driven, while NATO membership overlaps with many high-income markets where supply security, regulatory compliance, and public health preparedness influence procurement priorities.

Key Country Insights in the Female Contraceptive Market

In the United States, contraceptive access is shaped by insurance coverage, state-level policy variation, telehealth, pharmacy services, and the landmark availability of an FDA-approved over-the-counter daily oral contraceptive. Canada emphasizes publicly guided healthcare access and provincial delivery models, while Mexico and Brazil remain important Latin American markets where affordability, public sector availability, and pharmacy access strongly influence uptake.

The United Kingdom, Germany, France, Italy, and Spain benefit from established reproductive health systems, though access models differ by reimbursement rules, pharmacy roles, primary care capacity, and national guidance. Russia represents a distinct market with local prescribing patterns, regulatory considerations, and healthcare delivery factors that affect product mix and patient access.

China and India anchor Asia’s contraceptive volume potential, with demand influenced by demographics, public health programs, domestic manufacturing, private healthcare expansion, and urban-rural disparities. Japan, South Korea, and Australia are more mature healthcare markets where clinical guidance, safety perception, reimbursement, and women’s health awareness influence adoption of pills, IUDs, implants, injectables, and emergency contraception.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize method choice, affordability, safety communication, and continuity of supply. Competitive advantage will come from portfolios that balance oral contraceptives, emergency contraception, barrier methods, and long-acting reversible methods while supporting clear counseling materials and medically accurate digital education.

Organizations should strengthen pharmacovigilance, invest in demand planning, and develop access partnerships with pharmacies, telehealth providers, NGOs, public health agencies, and trained clinicians. Regional strategies should be tailored to reimbursement systems, cultural context, regulatory requirements, clinician training, and procurement mechanisms rather than relying on a single global commercialization model.

Research Methodology

This executive summary is built from secondary research grounded in recognized public health and regulatory sources, including WHO, UNFPA, UNICEF, CDC, national health agencies, peer-reviewed literature, and medicine regulatory authorities. The analysis emphasizes verified indicators such as contraceptive need, method mix, access barriers, policy changes, safety guidance, and healthcare delivery trends.

Market interpretation uses triangulation across epidemiological evidence, regulatory developments, product availability, demographic patterns, clinical guidelines, and healthcare infrastructure. Insights are presented qualitatively to avoid unsupported market sizing and to maintain a data-backed, decision-useful view of the female contraceptive market.

Conclusion

The female contraceptive market is evolving through broader method choice, digital access, policy reform, and stronger expectations for safety, affordability, privacy, and equity. Opportunities exist across mature and emerging regions, but success depends on aligning products with clinical evidence, patient preferences, regulatory standards, and local access realities.

Organizations that combine reliable supply, responsible AI, evidence-based education, and region-specific partnerships will be best positioned to serve women’s reproductive health needs and strengthen their role in the global family planning ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Female Contraceptive Market, by Product Type
7.1. Implants
7.2. Injectables
7.3. Intrauterine Devices
7.3.1. Copper IUD
7.3.2. Hormonal IUD
7.4. Pills
7.4.1. Combined Pill
7.4.1.1. First Generation
7.4.1.2. Fourth Generation
7.4.1.3. Second Generation
7.4.1.4. Third Generation
7.4.2. Progestin Only Pill
8. Female Contraceptive Market, by Mechanism
8.1. Hormonal
8.1.1. Combined
8.1.2. Progestin Only
8.2. Non-Hormonal
9. Female Contraceptive Market, by End User Age
9.1. 15-24 Years
9.2. 25-34 Years
9.3. 35-49 Years
10. Female Contraceptive Market, by Distribution Channel
10.1. Clinics
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Asia-Pacific Female Contraceptive Market
12. Europe Female Contraceptive Market
13. North America Female Contraceptive Market
14. Latin America Female Contraceptive Market
15. Africa Female Contraceptive Market
16. Middle East Female Contraceptive Market
17. NATO Female Contraceptive Market
18. G7 Female Contraceptive Market
19. BRICS Female Contraceptive Market
20. European Union Female Contraceptive Market
21. ASEAN Female Contraceptive Market
22. GCC Female Contraceptive Market
23. China Female Contraceptive Market
24. United States Female Contraceptive Market
25. Japan Female Contraceptive Market
26. India Female Contraceptive Market
27. Germany Female Contraceptive Market
28. United Kingdom Female Contraceptive Market
29. Australia Female Contraceptive Market
30. France Female Contraceptive Market
31. South Korea Female Contraceptive Market
32. Italy Female Contraceptive Market
33. Canada Female Contraceptive Market
34. Russia Female Contraceptive Market
35. Brazil Female Contraceptive Market
36. Mexico Female Contraceptive Market
37. Spain Female Contraceptive Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. Abbvie Inc.
39.2. Acme Generics Pvt. Ltd.
39.3. Afaxys, Inc.
39.4. Agile Therapeutics, Inc.
39.5. Amneal Pharmaceuticals LLC
39.6. ASKA Pharmaceutical Co., Ltd.
39.7. Aurobindo Pharma Limited
39.8. Bayer AG
39.9. Cipla Limited
39.10. HLL Lifecare Limited
39.11. Insud Pharma, S.L.
39.12. Lupin Limited
39.13. Mayne Pharma Group Limited
39.14. Merck & Co., Inc.
39.15. Mithra Pharmaceuticals S.A.
39.16. Okamoto Industries, Inc.
39.17. Organon & Co.
39.18. Perrigo Company PLC
39.19. Pfizer Inc.
39.20. Piramal Pharma Ltd.
39.21. Ritex GmbH
39.22. Sanofi S.A.
39.23. Say It With A Condom, LLC
39.24. Syzygy Healthcare Solutions LLC
39.25. Teva Pharmaceutical Industries Ltd.
39.26. TherapeuticsMD, Inc.
39.27. TTK Healthcare Limited
39.28. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025 VS 2032 (%)
FIGURE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INJECTABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INJECTABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COPPER IUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COPPER IUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COPPER IUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HORMONAL IUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HORMONAL IUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HORMONAL IUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COMBINED PILL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COMBINED PILL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COMBINED PILL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FIRST GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FIRST GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FIRST GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FOURTH GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FOURTH GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FOURTH GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SECOND GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SECOND GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SECOND GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THIRD GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THIRD GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THIRD GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PROGESTIN ONLY PILL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PROGESTIN ONLY PILL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PROGESTIN ONLY PILL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HORMONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HORMONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HORMONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COMBINED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COMBINED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COMBINED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PROGESTIN ONLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PROGESTIN ONLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PROGESTIN ONLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NON-HORMONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NON-HORMONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NON-HORMONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL 15-24 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL 15-24 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL 15-24 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL 25-34 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL 25-34 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL 25-34 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL 35-49 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL 35-49 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL 35-49 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 93. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 94. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 95. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 96. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 98. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 120. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 121. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 122. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 123. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 124. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 125. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 138. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 139. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 140. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 141. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 142. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 143. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 147. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 148. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 149. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 150. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 151. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 152. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 156. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 157. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 158. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 159. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 160. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 161. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 174. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 175. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 176. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 177. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 178. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 179. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 183. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 184. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 185. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 186. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 187. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 188. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 192. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 193. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 194. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 195. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 196. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 197. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 208. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 210. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 211. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 212. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 213. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 214. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 215. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 217. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 219. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 220. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 221. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 222. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 223. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 224. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 226. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 228. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 229. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 230. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 231. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 232. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 233. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 243. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 244. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 245. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 246. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 247. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 248. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 249. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 250. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 251. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 255. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 256. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 257. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 258. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 259. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 260. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 264. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 265. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 266. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 267. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 268. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 269. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 271. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 273. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 274. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 275. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 276. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 277. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 278. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 280. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 281. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 282. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 283. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 284. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 285. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 286. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 287. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 289. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 290. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 291. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 292. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 293. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 294. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 295. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 296. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 297. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 298. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 299. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 300. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 301. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 302. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 303. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 304. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 305. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 306. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 307. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 308. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 309. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 310. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 311. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 312. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 313. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 314. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 315. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 316. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 317. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 318. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 319. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 320. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 321. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 322. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 323. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Female Contraceptive market report include:
  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Cipla Limited
  • HLL Lifecare Limited
  • Insud Pharma, S.L.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals S.A.
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Ritex GmbH
  • Sanofi S.A.
  • Say It With A Condom, LLC
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 18.4 Billion
Forecasted Market Value ( USD ) by 2032 $ 29.55 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Contraceptive Market by Product Type, Mode of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast 2026-2032 - Product Image

Contraceptive Market by Product Type, Mode of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Female Emergency Contraceptive Pill Market - Global Forecast 2026-2032 - Product Image

Female Emergency Contraceptive Pill Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Contraceptive Devices Market Report 2026 - Product Image

Contraceptive Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2026-2034 - Product Image

Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From

About the Female Contraceptive Market

The Female Contraceptive market is an important part of Women's Health, providing women with the ability to control their reproductive health. Contraceptives are used to prevent pregnancy, and can be divided into two main categories: hormonal and non-hormonal. Hormonal contraceptives, such as the pill, patch, and ring, use hormones to prevent ovulation and fertilization. Non-hormonal contraceptives, such as condoms, diaphragms, and spermicides, work by blocking sperm from entering the uterus. In addition to preventing pregnancy, contraceptives can also be used to treat a variety of conditions, such as endometriosis, polycystic ovary syndrome, and acne. Contraceptives can also be used to regulate menstrual cycles and reduce the risk of certain cancers. Some companies in the Female Contraceptive market include Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.